Detecting factor XIa in immune globulin products: Commutability of international reference materials for traditional and global hemostasis assays
Abstract Background Activated coagulation factor XIa (FXIa) is an impurity and primary source of procoagulant activity in thrombosis‐implicated immune globulin (IG) products. Several assays, of varying quality and precision are used to assess FXIa‐like procoagulant activity in units relevant to thei...
Main Authors: | Yideng Liang, Joseph W. Jackson, Samuel A. Woodle, Stepan S. Surov, Leonid A. Parunov, Dorothy E. Scott, Mark Weinstein, Timothy K. Lee, Mikhail V. Ovanesov |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-01-01
|
Series: | Research and Practice in Thrombosis and Haemostasis |
Subjects: | |
Online Access: | https://doi.org/10.1002/rth2.12467 |
Similar Items
-
Combined thrombogenic effects of vessel injury, pregnancy and procoagulant immune globulin administration in mice
by: Yanqun Xu, et al.
Published: (2020-11-01) -
Comparative Analysis of Thrombin Calibration Algorithms and Correction for Thrombin-α2macroglobulin Activity
by: William C. Chang, et al.
Published: (2020-09-01) -
Fluorescence artifact correction in the thrombin generation assay: Necessity for correction algorithms in procoagulant samples
by: William C. Chang, et al.
Published: (2021-03-01) -
Improved efficacy/safety profile of factor XIa inhibitor BMS‐724296 versus factor Xa inhibitor apixaban and thrombin inhibitor dabigatran in cynomolgus monkeys
by: Pancras C. Wong, et al.
Published: (2021-05-01) -
Comparative Thrombin Generation in Animal Plasma: Sensitivity to Human Factor XIa and Tissue Factor
by: Yideng Liang, et al.
Published: (2023-08-01)